These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 24152154)
1. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling. van der Schee MP; Palmay R; Cowan JO; Taylor DR Clin Exp Allergy; 2013 Nov; 43(11):1217-25. PubMed ID: 24152154 [TBL] [Abstract][Full Text] [Related]
2. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma. Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990 [TBL] [Abstract][Full Text] [Related]
3. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers. Hillas G; Kostikas K; Mantzouranis K; Bessa V; Kontogianni K; Papadaki G; Papiris S; Alchanatis M; Loukides S; Bakakos P Respirology; 2011 Jul; 16(5):811-8. PubMed ID: 21545371 [TBL] [Abstract][Full Text] [Related]
4. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610 [TBL] [Abstract][Full Text] [Related]
6. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of noninvasive methods for the study of bronchial inflammation in the control of patients with asthma. Muñoz X; Bustamante V; Lopez-Campos JL; Cruz MJ; Barreiro E Int Arch Allergy Immunol; 2015; 166(1):1-12. PubMed ID: 25765083 [TBL] [Abstract][Full Text] [Related]
8. Association between exhaled inflammatory markers and asthma control in children. Van Vliet D; Smolinska A; Jöbsis Q; Rosias PP; Muris JW; Dallinga JW; van Schooten FJ; Dompeling E J Breath Res; 2016 Feb; 10(1):016014. PubMed ID: 26893372 [TBL] [Abstract][Full Text] [Related]
9. Sputum interleukin-13 as a biomarker for the evaluation of asthma control. Tsilogianni Z; Hillas G; Bakakos P; Aggelakis L; Konstantellou E; Papaioannou AI; Papaporfyriou A; Papiris S; Koulouris N; Loukides S; Kostikas K Clin Exp Allergy; 2016 Jul; 46(7):923-31. PubMed ID: 26990030 [TBL] [Abstract][Full Text] [Related]
10. Safety and application of induced sputum analysis in childhood asthma. Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559 [TBL] [Abstract][Full Text] [Related]
12. Effects of steroid therapy on inflammatory cell subtypes in asthma. Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343 [TBL] [Abstract][Full Text] [Related]
13. In moderate-to-severe asthma patients monitoring exhaled nitric oxide during exacerbation is not a good predictor of spirometric response to oral corticosteroid. Gelb AF; Moridzadeh R; Singh DH; Fraser C; George SC J Allergy Clin Immunol; 2012 Jun; 129(6):1491-8. PubMed ID: 22560478 [TBL] [Abstract][Full Text] [Related]
14. Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma. Schleich FN; Zanella D; Stefanuto PH; Bessonov K; Smolinska A; Dallinga JW; Henket M; Paulus V; Guissard F; Graff S; Moermans C; Wouters EFM; Van Steen K; van Schooten FJ; Focant JF; Louis R Am J Respir Crit Care Med; 2019 Aug; 200(4):444-453. PubMed ID: 30973757 [No Abstract] [Full Text] [Related]
15. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998 [TBL] [Abstract][Full Text] [Related]
16. Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic. LaForce C; Brooks E; Herje N; Dorinsky P; Rickard K Ann Allergy Asthma Immunol; 2014 Dec; 113(6):619-23. PubMed ID: 25060819 [TBL] [Abstract][Full Text] [Related]
17. Cutoff point for exhaled nitric oxide corresponding to 3% sputum eosinophils. Alvarez-Puebla MJ; Olaguibel Rivera JM; Almudevar E; Echegoyen AA; de Esteban Chocarro B; Cambra K J Investig Allergol Clin Immunol; 2015; 25(2):107-11. PubMed ID: 25997303 [TBL] [Abstract][Full Text] [Related]
18. Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy-based study. Vijverberg SJ; Koster ES; Koenderman L; Arets HG; van der Ent CK; Postma DS; Koppelman GH; Raaijmakers JA; Maitland-van der Zee AH Pediatr Allergy Immunol; 2012 Sep; 23(6):529-36. PubMed ID: 22624949 [TBL] [Abstract][Full Text] [Related]
19. Breath profiles by electronic nose correlate with systemic markers but not ozone response. Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804 [TBL] [Abstract][Full Text] [Related]
20. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma. Kanniess F; Richter K; Böhme S; Jörres RA; Magnussen H Pulm Pharmacol Ther; 2001; 14(2):141-7. PubMed ID: 11273796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]